All Eyes On Sanofi’s MS Efforts As Aubagio Plummets Upon Generic Entries

Dupixent Still On The Rise

 
• By Ayisha Sharma
  
doctor holding mri brain scan images
Frexalimab reduced new gadolinium-enhancing T1 brain lesions by 89% • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business